大富科技(300134.SZ):子公司大凌實業擬停產歇業
格隆匯11月20日丨大富科技(300134.SZ)公佈,公司控股子公司廣州大凌實業股份有限公司(“大凌實業”),截至2019年9月30日(未經審計)總資產約1.08億元,負債總額約1.58億元,淨資產約-5,000萬元。
為了遏制和減少虧損、降低損失、減少風險,大凌實業召開董事會決定大凌實業停產歇業。大凌實業的停產歇業不會對上市公司日常生產經營產生不利影響。
目前大凌實業面臨多方債務違約、多項訴訟糾紛、員工大規模離職等問題,現已停產歇業;公司向大凌實業提供的借款存在無法收回的風險;公司可能計提大額資產減值損失,直接影響公司當期及後期的利潤。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.